TIDMNSCI
NetScientific PLC
19 August 2016
("NetScientific" or the "Company" or the "Group")
myWanda Mobile App Launches to Help Women
Manage Heart Health with Personalized Guidance
myWanda is Wanda's first consumer app, making it easier for
women to receive support, education and guidance on heart
health
London, UK - 19 August 2016 - NetScientific plc
("NetScientific", AIM:NSCI), the transatlantic biomedical and
healthcare technology group, announces that its digital health
portfolio company, Wanda has launched myWanda, the first and only
mobile application aimed at empowering women to improve the health
of their hearts.
Commenting on the news, François R. Martelet, Chief Executive
Officer of NetScientific, said: "The myWanda mobile app now
available on the US iTunes App Store will serve to deliver
personalized support for developing healthy behaviours and ensure
patients are increasingly at the heart of the care process. This is
an important milestone for Wanda, and is line with the Company's
strategy to expand its platform of mobile applications to capture
patients earlier in their disease trajectory."
The full text of the announcement issued by Wanda on 18(th)
August 2016 is as follows:
myWanda Mobile App Launches to Help Women Manage Heart Health
With Personalized Guidance
myWanda Acts as a Personal Companion, Motivator, and Educator
for Women to Enable Them to Manage Their Heart Health
SAN FRANCISCO, CA--(Marketwired - Aug 18, 2016) - Wanda
(http://yourwanda.com/), a leading digital health platform
dedicated to advancing the effectiveness and efficiency of chronic
health condition management, today announced the launch of myWanda,
the first and only mobile application specifically aimed at
empowering women to improve the health of their hearts.
Wanda is expanding its analytics ecosystem with mobile
applications to engage individuals earlier in their lives,
onboarding them onto the Wanda platform. myWanda will also add
considerably to the richness of Wanda's data and machine-learning
engine, enabling the Company to advance upcoming product
applications and features.
Available today in the iTunes App Store, myWanda delivers
personalized support for developing heart healthy behaviors. The
app encourages women to set specific lifestyle goals known as
"Pathways" for exercise, nutrition, sleep, stress management, and
hydration. myWanda then delivers daily tips, advice, and
inspiration to help women stay on track to achieve these goals,
thereby creating measureable improvements to their heart health and
overall well-being.
Although heart disease is the number one killer of women in
America, approximately 80 percent of cases are preventable through
education and lifestyle changes. This is where myWanda comes in --
leveraging data science, applied medical research, and proven
engagement methodologies to deliver support through a compelling,
visually-driven mobile interface.
"myWanda is driving a revolution in healthcare that re-positions
the patient to the very center of the care process," said Dr.
Suzanne Steinbaum, renowned cardiologist and Medical Director of
Wanda. "I'm thrilled to align my passion for educating women about
heart health with myWanda's intelligent, impactful solution. Our
goal is to empower women with the tools and knowledge they need to
take control of their own health."
As Wanda's Medical Director, Dr. Steinbaum oversees the clinical
content, consumer engagement, and clinical integrity. Dr. Steinbaum
is a Fellow of the American College of Cardiology, and is the
National Spokesperson for the Go Red for Women campaign. Experience
and expertise has given Dr. Steinbaum a close view of the critical
role that technology plays in managing women's healthcare; and she
has seen in myWanda an innovative technology solution that stands
out among health apps and demonstrates the potential to improve
health, quality care, and convenience for women.
Wanda has long been dedicated to simplifying and improving the
lives of individuals with chronic health conditions, blending
predictive analytics and behavioral science to enrich the remote
health and patient management experience. Through its research,
Wanda identified the importance of proactively addressing the
unique needs of women who are at risk of heart disease today.
myWanda is the company's first consumer app, featuring a
leading-class personalized communication strategy that makes it
easy for women to receive support, education, and guidance.
"We're excited to bring a technology solution to market that can
truly inform, motivate, and support women to take better care of
their hearts, while continuing to advance our deep understanding of
chronic conditions and the individual behaviors which affect them,"
said Wanda CEO Steve Curd, who is also former CIO of
UnitedHealthCare and former COO of WebMD.
myWanda is already enjoying interest from large employers,
especially those in healthcare, hoping to promote myWanda to their
employees, members and communities. Such relationships with
healthcare organizations are expected to open doors for the
introduction and adoption of Wanda's core commercial solutions
which are designed to prevent costly and disruptive hospital
readmissions for those suffering with chronic diseases. The launch
of myWanda expands Wanda's mission to proactively interact with
people at various phases in the progression of disease -- from
earliest risk identification and prevention through diagnosis and
treatment. Most importantly, Wanda directly addresses the growing
demand for science-driven solutions for post-acute and
home-centered care.
"At Wanda, our approach has always been clear: how do we
translate the most advanced technological capabilities into
human-centered solutions," according to CCO Mark Heinemeyer. "The
myWanda app truly embodies the vision of harnessing powerful
technologies to improve people's lives."
To download myWanda in the iTunes App Store, please visit:
https://itunes.apple.com/us/app/mywanda/id1125216315?ls=1&mt=8
For more information on Wanda, please visit:
http://yourwanda.com/.
- Ends -
For more information, please contact:
NetScientific Tel: +44 (0)20 3514
François R. Martelet, 1800
M.D., CEO
Ian Postlethwaite, CFO
Stifel Nicolaus Europe Limited Tel: +44 (0) 20 7710
(NOMAD and broker) Jonathan 7600
Senior / David Arch / Ben
Maddison
Consilium Strategic Communications Tel: +44 (0)20 3709
Mary-Jane Elliott / Chris 5700
Gardner / Jessica Hodgson netscientific@consilium-comms.com
/ Chris Welsh / Laura Thornton
About NetScientific Plc
NetScientific is a biomedical and healthcare technology group
that funds and develops technologies that offer transformative
benefits to people's lives and society through improved diagnosis,
prognosis and treatment. For more information, please visit the
website at www.netscientific.net.
About Wanda
San Francisco-based Wanda is dedicated to advancing the
effectiveness and efficiency of medicine by using machine learning
in place of conventional technologies and by enabling clinicians to
make more informed care decisions. Wanda recognizes that remote
monitoring and algorithms cannot save lives or reduce
hospitalizations unless the individual and their caregivers are
promptly informed and highly engaged. Through the collaboration of
data science and applied medical research, Wanda has proven that
its inline analytics predict preventable events much better than
conventional methods. Wanda serves as a diligent companion,
providing encouragement and intelligent visual guidance that
simplifies and improves lives, while simultaneously helping
organizations reduce their care delivery costs. Wanda is a
NetScientific portfolio company. More information about Wanda can
be found at www.yourwanda.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
NRAPPMBTMBTBTFF
(END) Dow Jones Newswires
August 19, 2016 02:00 ET (06:00 GMT)
Netscientific (LSE:NSCI)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024
Netscientific (LSE:NSCI)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024